• Affiliate Assistant Professor, Global Health
  • Vice President, Corporate Development, Chembio Diagnostics Systems, Inc.
Phone Number: 
206-883-6160
Fax: 
Select from the following:
Biography 

Christine M. Rousseau, Ph.D. joined Chembio Diagnostics Systems, Inc. in July of 2018 as Vice President, Corporate Development. Prior to joining Chembio, Dr. Rousseau spent nine years at the Bill & Melinda Gates Foundation, most recently serving as Senior Program Officer, Global Health, Integrated Technology Solutions. While there, she directed over $250 million in assets for the development, commercialization, and scale-up of immune, molecular and cellular diagnostic technologies, including a significant role in HIV Self-Testing. In addition, Dr. Rousseau spent over ten years as a research scientist and faculty member at the University of Washington, with emphasis in the areas of HIV and HCV. Earlier in her career, she was a Senior Fellow at the Fred Hutchinson Cancer Research Center and HIV Director & Founding Board Member of the Sustainable Sciences Institute.

Education 
  • PhD (University of California (Berkeley))
  • MS (University of Washington)
  • BS (Ohio State University)
Country Affiliations 
Languages 
  • Spanish
Health Topics 
  • Biodefense Infectious Diseases
  • Brain Injury
  • Burden of Disease
  • Cardiovascular Disease
  • Ebola
  • Hepatitis
  • HIV/AIDS
  • Infectious Diseases
  • Infectious Diseases (other than STDs)
  • Leishmaniasis
  • Malaria
  • Mobile Health (mHealth)
  • Neglected Diseases, Tropical Medicine (incl. Parasites)
  • STDs (other than HIV)
  • Trop. Med (incl. Parasites)
  • Viruses